Evidence map›Paper›PMID 28716113›Full record

ArticleMicrobiome2017

Whole metagenome profiles of particulates collected from the International Space Station.

Nicholas A Be, Aram Avila-Herrera, Jonathan E Allen, Nitin Singh, Aleksandra Checinska Sielaff, Crystal Jaing, Kasthuri Venkateswaran

Erratum issuedAbstract read
In one paragraph

Article in Microbiome, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Riboflavin- and chlorophyllin-based antimicrobial photoinactivation ofFrontiers in cellular and infection microbiology · 2022
    Article
  20. A roadmap for metagenomic enzyme discovery.Natural product reports · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Nicholas A BePhysical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, USA.
Aram Avila-HerreraComputation Directorate, Lawrence Livermore National Laboratory, Livermore, CA, USA.
Jonathan E AllenComputation Directorate, Lawrence Livermore National Laboratory, Livermore, CA, USA.
Nitin SinghBiotechnology and Planetary Protection Group, Jet Propulsion Laboratory, California Institute of Technology, M/S 89-2, 4800 Oak Grove Dr., Pasadena, CA, 91109, USA.
Aleksandra Checinska SielaffBiotechnology and Planetary Protection Group, Jet Propulsion Laboratory, California Institute of Technology, M/S 89-2, 4800 Oak Grove Dr., Pasadena, CA, 91109, USA.
Crystal JaingPhysical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, USA.
Kasthuri VenkateswaranBiotechnology and Planetary Protection Group, Jet Propulsion Laboratory, California Institute of Technology, M/S 89-2, 4800 Oak Grove Dr., Pasadena, CA, 91109, USA. kjvenkat@jpl.nasa.gov.ORCID 0000-0002-6742-0873

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe built environment of the International Space Station (ISS) is a highly specialized space in terms of both physical characteristics and habitation requirements. It is unique with respect to conditions of microgravity, exposure to space radiation, and increased carbon dioxide concentrations. Additionally, astronauts inhabit a large proportion of this environment. The microbial composition of ISS particulates has been reported; however, its functional genomics, which are pertinent due to potential impact of its constituents on human health and operational mission success, are not yet characterized.

methodsThis study examined the whole metagenome of ISS microbes at both species- and gene-level resolution. Air filter and dust samples from the ISS were analyzed and compared to samples collected in a terrestrial cleanroom environment. Furthermore, metagenome mining was carried out to characterize dominant, virulent, and novel microorganisms. The whole genome sequences of select cultivable strains isolated from these samples were extracted from the metagenome and compared.

resultsSpecies-level composition in the ISS was found to be largely dominated by Corynebacterium ihumii GD7, with overall microbial diversity being lower in the ISS relative to the cleanroom samples. When examining detection of microbial genes relevant to human health such as antimicrobial resistance and virulence genes, it was found that a larger number of relevant gene categories were observed in the ISS relative to the cleanroom. Strain-level cross-sample comparisons were made for Corynebacterium, Bacillus, and Aspergillus showing possible distinctions in the dominant strain between samples.

conclusionSpecies-level analyses demonstrated distinct differences between the ISS and cleanroom samples, indicating that the cleanroom population is not necessarily reflective of space habitation environments. The overall population of viable microorganisms and the functional diversity inherent to this unique closed environment are of critical interest with respect to future space habitation. Observations and studies such as these will be important to evaluating the conditions required for long-term health of human occupants in such environments.

Indexed as

MetagenomeMicrobiotaSpacecraftArchaeaAstronautsBacteriaDustEnvironment, ControlledEnvironment DesignHigh-Throughput Nucleotide SequencingHumansInternational AgenciesMetagenomicsPhylogenySpace FlightWeightlessnessDustBuilt environmentCleanroomFunctional metagenomicsInternational Space StationMicrobiomePropidium monoazide

Identifiers

PMID28716113
PMCPMC5514531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.